Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
62
days
Association Between Efficacy and Pharmacokinetics of DMB-3115 and its Originator Ustekinumab in Patients with Chronic Plaque Psoriasis: An Exposure–Response Analysis
AuthorsHironori Konishi; Takeyuki Shindo; Kazuya Ishiwata; Jun Morita
Affiliations1. R&D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Japan
62
days
Pharmacokinetics, Safety, and Immunogenicity of DMB-3115, a Ustekinumab Biosimilar for Immune-Mediated Diseases, in Healthy Japanese Male Participants: A Randomized, Double-Blind, Single-Dose Study
AuthorsHironori Konishi; Takeyuki Shindo; Michio Yagi; Takashi Eto; Rie Yazawa; Makoto Yono; Naoki Cho; Hideki Fushimi; Jun Morita
Affiliations1. R and D Division, Meiji Seika Pharma Co., Ltd., Tokyo, Japan; 2. Medical Corporation Heishinkai OPHAC Hospital, Osaka, Japan; 3. Souseikai Hakata Clinic, Fukuoka, Japan; 4. Souseikai Sumida Hospital, Tokyo, Japan; 5. Souseikai Nishikumamoto Hospital, Kumamoto, Japan
112
days
Costs of Comorbidities and Complications Associated with Type 2 Diabetes: A Retrospective, Cohort Study
AuthorsKendra A. Terrell; Maureen J. Lage; William J. Valentine; Jim S. Paik; Kristina S. Boye
Affiliations1. Eli Lilly and Company, Lilly Corporate Center, Indianapolis, USA; 2. HealthMetrics Outcomes Research, Branford, USA; 3. Ossian Health Economics and Communications, Basel, Switzerland
56
days
An Examination into the Anti-stress and Anti-fatigue Effects of an Ashwagandha Extract (Ashwa.30™) in Stressed Adults: A Randomised, Double-Blind, Placebo-controlled Trial
AuthorsAdrian L. Lopresti; Stephen J. Smith; Bharathi Bethapudi; Auxi Arobana R; Deepak Mundkinajeddu; Prashanth D’Souza; Suresh Lakshmikanthan
Affiliations1. Clinical Research Australia, Duncraig, Perth, Australia; 2. College of Science, Health, Engineering and Education, Murdoch University, Perth, Australia; 3. Natural Remedies Pvt Ltd, Bengaluru, India
180
days
Humanistic Burden and Gaps in Care and Treatment Policies of Obesity in Canada: A Systematic Review
AuthorsChristine Longuet; Esther Artime; Jennifer Glass; Sam Riley; Rachel Kewley; Jennifer L. Kuk; Ian Patton; David C. W. Lau
Affiliations1. Eli Lilly and Company, Toronto, Canada; 2. Eli Lilly and Company, Madrid, Spain; 3. Formerly Adelphi Values PROVE, Bollington, UK; 4. School of Kinesiology and Health Science, York University, Toronto, Canada; 5. Obesity Canada – Obesité Canada, 2-126 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, Canada; 6. Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Canada
35
days
Real-World Adult Height Outcomes in Girls with Central Precocious Puberty Receiving GnRHa Monotherapy or Combined with Growth Hormone: A Cohort Study in China
AuthorsFei Wang; Yan Li; Yu Yang; Wei Gu; Xuan Xu; Haiying Wu; Guimei Li; Xiaoqin Yin; Shasha Zhou; Pin Li
Affiliations1. Department of Endocrinology, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; 2. Department of Endocrinology, Genetics and Metabolism, Jiangxi Provincial Children’s Hospital, Nanchang, China; 3. Department of Endocrinology, Genetics and Metabolism, Children’s Hospital of Nanjing Medical University, Nanjing, China; 4. Department of Pediatric Endocrinology, Hunan Provincial People’s Hospital, Changsha, China; 5. Department of Endocrinology, Genetics and Metabolism, Children’s Hospital of Soochow University, Suzhou, China; 6. Department of Pediatrics, Shandong Provincial Hospital, Jinan, China
45
days
Sacral Neuromodulation for Refractory Overactive Bladder: Closing the Gaps in Anatomy, Mechanisms, and Parameter Selection
AuthorsDaniel P. Marshall; Isha Chugh; Cindy L. Amundsen; Nazema Y. Siddiqui; Warren M. Grill
Affiliations1. Department of Biomedical Engineering, Duke University, Durham, USA; 2. Department of Electrical and Computer Engineering, Duke University, Durham, USA; 3. Department of Obstetrics and Gynecology, Urogynecology, Duke University, Durham, USA; 4. Department of Urology, Duke University, Durham, USA; 5. Department of Neurobiology, Duke University, Durham, USA; 6. Department of Neurosurgery, Duke University, Durham, USA
63
days
Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors Study
AuthorsKelly G. Gwathmey; Panru Jing; Scott Laorr; Joe Koo; Sanjay Rakhade; Emmett Alton Sartor; J. T. Tibung; Jason Murray; Christina Laskar
Affiliations1. VCU Health, Virginia Commonwealth University, Richmond, USA; 2. Insight by Nemera, Chicago, USA; 3. Alexion, AstraZeneca Rare Disease, Boston, USA; 4. AstraZeneca, Boston, USA; 5. Alexion, AstraZeneca Rare Disease, Zurich, Switzerland
120
days
Matching-Adjusted Indirect Comparison of Tarlatamab for Patients with Platinum-Refractory or Platinum-Resistant Extensive-Stage Small-Cell Lung Cancer
AuthorsFranziska Dirnberger; Sachin Patel; Devon J. Boyne; Zhiyi Lan; Jenny Uyei; Jessie Wang; Seoyoon Cho; Lucy DeCosta; Ian M. Bridges; Umit Tapan
Affiliations1. Amgen GmbH, Munich, Germany; 2. Amgen Ltd, Uxbridge, UK; 3. IQVIA Inc., Kirkland, Canada; 4. IQVIA Inc., San Mateo, USA; 5. Amgen Inc, Thousand Oaks, USA; 6. Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, and Boston Medical Center, Boston, USA
137
days
Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative Review
AuthorsBradley C. Gill; Matt T. Rosenberg; Steven A. Kaplan; Lori B. Lerner
Affiliations1. Lerner College of Medicine, Cleveland Clinic, Cleveland, USA; 2. Department of Urology, Cleveland Clinic, Cleveland, USA; 3. Mid-Michigan Health Centers, Jackson, USA; 4. Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA; 5. VA Boston Healthcare System, Boston, USA
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days